Sep 28, 2017 12:15 pm UTC| Business
DALLAS, Sept. 28, 2017 -- Wingstop Restaurants Inc. (NASDAQ:WING), the award-winning wing concept with more than 1,000 locations worldwide, today announced that it is extending its global reach by expanding into France....
KEMET Corporation Set to Join S&P SmallCap 600 Index
Sep 28, 2017 12:15 pm UTC| Business
GREENVILLE, S.C., Sept. 28, 2017 -- KEMET Corporation (NYSE:KEM), a leading global supplier of passive electronic components, announced today that it is set to join the SP SmallCap 600 index effective prior to the...
Sky Solar Holdings, Ltd. Reports Unaudited Financial Results for First Half of Fiscal Year 2017
Sep 28, 2017 12:10 pm UTC| Business
HONG KONG, Sept. 28, 2017 -- Sky Solar Holdings, Ltd. (NASDAQ:SKYS) (“Sky Solar” or “the Company”), a global developer, owner and operator of solar parks, today announced its financial results for the first six months...
La SITI is Now Offering Scholarships to American Actors
Sep 28, 2017 12:10 pm UTC| Business
LOS ANGELES, Sept. 28, 2017 -- La SITI is opening its doors to international students by offering $11,000 worth of one-year scholarships for aspiring American actors. Scholarship recipients will learn the Italian...
Herb Oil Market is estimated to be worth US$ 350 million by end 2022 – Future Market Insights
Sep 28, 2017 12:03 pm UTC| Business
Valley Cottage, NY, Sept. 28, 2017 -- Herb oils have become very popular in the 21st century as consumers seek out ‘natural and organic’ solutions that fit into their active lifestyles and have minimal to no-side...
ICYMI: Evine Debuted “Evine After Dark” and Customers are Buzzing
Sep 28, 2017 12:03 pm UTC| Business
MINNEAPOLIS, Sept. 28, 2017 -- Evine Live Inc. (“Evine”) (NASDAQ:EVLV), a multiplatform interactive digital commerce company (evine.com) introduced a new late-night shopping experience and TV talk show last weekend...
Caladrius Biosciences to Participate at the 2017 Cell & Gene Meeting on the Mesa
Sep 28, 2017 12:01 pm UTC| Business
BASKING RIDGE, N.J., Sept. 28, 2017 -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius” or the “Company”), a development-stage biopharmaceutical company with multiple technology platforms targeting autoimmune and...